Update shared on 11 Nov 2025
Analysts have maintained their price target for China Literature at approximately $39.17. They cite updated discount rate assumptions that reflect a slightly more cautious outlook, while forecasts for growth and profitability remain stable.
What's in the News
- China Literature completed the repurchase of 6,138,800 shares, representing 0.6%, for HKD 152.84 million as part of a buyback tranche running from January 1, 2025 to May 30, 2025 (Key Developments).
- The company has completed a cumulative repurchase of 13,865,800 shares, representing 1.36%, for HKD 422.78 million under the buyback announced on June 21, 2024 (Key Developments).
- From June 2, 2025 to June 30, 2025, China Literature repurchased an additional 200,000 shares, or 0.02%, for HKD 5.18 million (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at HK$39.17.
- Discount Rate has risen slightly from 6.89% to 7.02%.
- Revenue Growth forecast is steady at approximately 8.3%.
- Net Profit Margin estimate remains largely unchanged at about 19.1%.
- Future P/E multiple has increased marginally from 25.04x to 25.19x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.